Potential of mobile intraoperative radiotherapy technology.
Mobile IORT units have the potential to change the way patients who have cancer are treated. The integration of IORT into cancer treatment programs, made possible by the new technologies of mobile linear accelerators that can be used in unshielded operating rooms, makes IORT significantly less time-consuming, less costly, and less risky to administer. It is now practical for IORT to be used in early-stage disease, in addition to advanced disease, and in sites for which patient transportation in the middle of surgery is considered too risky. Preliminary results of trials for early-stage breast and rectal cancer indicate benefits of IORT. Pediatric patients and patients who have lung cancer, previously underserved by IORT therapies, can be offered potential gains when patient transport issues do not limit IORT. Furthermore, because many of these mobile systems require no shielding, it is now practical for mobile units to be shared between hospitals, making this new mobile technology much more widely available.
Intraop Medical, Inc., 3170 De La Cruz Boulevard, Suite 108, Santa Clara, CA 95054, USA.
Donald A
DA
Goer
Chapple W
CW
Musslewhite
David M
DM
Jablons
D000328:Adult; D002648:Child; D006801:Humans; D007432:Intraoperative Period; D009369:Neoplasms / Q000532:radiotherapy* / Q000601:surgery; D018714:Radiotherapy, Adjuvant / Q000295:instrumentation* / Q000379:methods